Allstate (NYSE:ALL) PT Raised to $215.00

Allstate (NYSE:ALL) had its price target boosted by equities research analysts at Morgan Stanley from $202.00 to $215.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the insurance provider’s stock. Morgan Stanley’s price objective indicates a potential upside of 11.61% from the stock’s current price.

A number of other research firms have also weighed in on ALL. Roth Mkm reissued a “buy” rating and issued a $200.00 target price on shares of Allstate in a research note on Wednesday, August 14th. The Goldman Sachs Group raised their target price on shares of Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research note on Thursday, August 15th. UBS Group raised their target price on shares of Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. JPMorgan Chase & Co. lifted their price target on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Finally, Wells Fargo & Company reduced their price target on shares of Allstate from $177.00 to $175.00 and set an “equal weight” rating on the stock in a research report on Friday, August 16th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $206.44.

Allstate Price Performance

ALL stock traded down $2.73 during trading on Monday, hitting $192.64. The stock had a trading volume of 1,163,214 shares, compared to its average volume of 1,546,520. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36. Allstate has a twelve month low of $121.70 and a twelve month high of $198.79. The stock has a market capitalization of $50.84 billion, a P/E ratio of 42.53, a PEG ratio of 1.74 and a beta of 0.48. The company’s 50-day moving average price is $186.66 and its two-hundred day moving average price is $173.81.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business had revenue of $15.71 billion for the quarter, compared to analyst estimates of $14.04 billion. During the same period last year, the company posted ($4.42) EPS. The business’s revenue was up 12.4% on a year-over-year basis. As a group, research analysts predict that Allstate will post 15.19 EPS for the current fiscal year.

Insiders Place Their Bets

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock worth $34,967,665 over the last 90 days. Corporate insiders own 1.80% of the company’s stock.

Hedge Funds Weigh In On Allstate

Institutional investors and hedge funds have recently modified their holdings of the company. Northwest Investment Counselors LLC acquired a new position in shares of Allstate during the first quarter worth $26,000. Versant Capital Management Inc grew its stake in shares of Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares in the last quarter. Family Firm Inc. acquired a new position in shares of Allstate during the second quarter worth $38,000. MCF Advisors LLC grew its stake in shares of Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares in the last quarter. Finally, Sunbelt Securities Inc. grew its stake in shares of Allstate by 38.5% during the first quarter. Sunbelt Securities Inc. now owns 363 shares of the insurance provider’s stock worth $63,000 after purchasing an additional 101 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.